India's COVID-19 tally climbs to 1,32,05,926 with over 1.45 lakh fresh cases

The active caseload was at its lowest at 1,35,926 on February 12, accounting for only 1.25 per cent of the total number of cases in the country.

PTI

April 10, 2021 / 10:26 IST

With a record 1,45,384 fresh cases, India's COVID-19 tally has climbed to 1,32,05,926, the health ministry said on Saturday.

The number of active cases has breached the 10-lakh mark again after around six-and-a-half months, while the death toll due to the viral disease has gone up to 1,68,436 with 794 more fatalities, the highest since October 18 last year, the ministry's data updated at 8 am showed.

Registering a steady increase for the 31st day in a row, the number of active coronavirus cases in the country has gone up to 10,46,631, accounting for 7.93 per cent of its total caseload, while the recovery rate has further dropped to 90.80 per cent.

The active caseload was at its lowest at 1,35,926 on February 12, accounting for only 1.25 per cent of the total number of cases in the country. The number of people who have recuperated from the disease has surged to 1,19,90,859, while the case fatality rate has further dropped to 1.28 per cent, the data stated.

India's COVID-19 tally had crossed the 20-lakh mark on August 7 last year, the 30-lakh mark on August 23, the 40-lakh mark on September 5 and the 50-lakh mark on September 16. It went past 60 lakh on September 28, 70 lakh on October 11, 80 lakh on October 29, 90 lakh on November 20 and the one-crore mark on December 19.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show